On Demand 2016 Practical Advice for the Diagnosis/Management of Drug Allergy (MOC)

Price: $19 members, $29 non-members

You can earn up to 1.5 AMA PRA Category 1 Credit(s). This activity has also been designated by the ABAI for 1.5 MOC Part II Self-Assessment credits. 

The majority of patients reporting penicillin allergy are not truly allergic. Avoidance of penicillin/beta-lactam antibiotics leads to using broader-spectrum, more expensive antibiotics. Rapid desensitization pursued unnecessarily also results in higher costs. This session will allow participants to optimize evaluations of patients reporting drug allergies, leading to improved, cost-effective care.

Release Date: 12/01/2016

Expiration Date: 11/30/2019


The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Learning Objectives

  • Optimize the evaluation of a patient reporting a drug allergy using a focused history
  • Discuss cost effective methods for using skin testing and drug challenge to evaluate patients reporting a drug allergy
  • Understand when cephalosporins can be used safely despite a history of PCN allergy
Additional information
  • David A. Khan, MD, FACAAI, Moderator -- Speaker: Genentech
  • Aleena Banerji, MD – Nothing to disclose
  • Eric M. Macy, MD – Supported/Contracted Research: ALK
  • Roland Solensky, MD, FACAAI – Nothing to disclose


Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
  • 1.50 MOC
Course opens: 
Course expires: 

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
  • 1.50 MOC


Please login or create an account to take this course.